These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22593849)

  • 21. Predicting the result of additional second-trimester markers from a woman's first-trimester marker profile: a new concept in Down syndrome screening.
    Maymon R; Cuckle H; Jones R; Reish O; Sharony R; Herman A
    Prenat Diagn; 2005 Dec; 25(12):1102-6. PubMed ID: 16231324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-invasive prenatal diagnosis for Down syndrome: the paradigm will shift, but slowly.
    Benn P; Cuckle H; Pergament E
    Ultrasound Obstet Gynecol; 2012 Feb; 39(2):127-30. PubMed ID: 22278776
    [No Abstract]   [Full Text] [Related]  

  • 23. [Rapid prenatal diagnosis of Down's syndrome in the first trimester of pregnancy by fluorescence in situ hybridization].
    Xiang Y; Sun N; Wang F
    Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):646-8. PubMed ID: 9639761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maternal serum triple analyte screening in pregnancy.
    Cate S
    Am Fam Physician; 2000 Aug; 62(4):738, 740. PubMed ID: 10969855
    [No Abstract]   [Full Text] [Related]  

  • 25. Incorporating first-trimester Down syndrome studies into prenatal screening: executive summary of the National Institute of Child Health and Human Development workshop.
    Reddy UM; Mennuti MT
    Obstet Gynecol; 2006 Jan; 107(1):167-73. PubMed ID: 16394055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low MSAFP and new biochemical markers for Down syndrome: implications for genetic counselors.
    Kloza EM
    Birth Defects Orig Artic Ser; 1990; 26(3):31-43. PubMed ID: 1709365
    [No Abstract]   [Full Text] [Related]  

  • 27. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
    Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
    Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Costs and effects of prenatal screening methods for Down syndrome and neural tube defects.
    Hoogendoorn M; Evers SM; Schielen PC; van Genugten ML; de Wit GA; Ament AJ
    Community Genet; 2008; 11(6):359-67. PubMed ID: 18690004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First-trimester tests for trisomies 21 and 18 as sensitive as triple screen.
    Lewis PR; Pasalio R
    J Fam Pract; 2004 Mar; 53(3):184-6. PubMed ID: 15000919
    [No Abstract]   [Full Text] [Related]  

  • 30. The quadruple test for Down syndrome screening in pregnant women of advanced maternal age.
    Kwon JY; Park IY; Kwon SM; Kim CJ; Shin JC
    Arch Gynecol Obstet; 2012 Mar; 285(3):629-33. PubMed ID: 21837420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequencing-based tests to determine fetal down syndrome (trisomy 21) from maternal plasma DNA.
    BlueCross BlueShield Association
    Technol Eval Cent Assess Program Exec Summ; 2013 Apr; 27(10):1-6. PubMed ID: 23866392
    [No Abstract]   [Full Text] [Related]  

  • 32. Elevated levels of total (maternal and fetal) beta-globin DNA in maternal blood from first trimester pregnancies with trisomy 21.
    Jorgez CJ; Dang DD; Wapner R; Farina A; Simpson JL; Bischoff FZ
    Hum Reprod; 2007 Aug; 22(8):2267-72. PubMed ID: 17584747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interstitial deletion of chromosome 7q and the lack of association with Down syndrome screening markers.
    Hafen LB; Rose NC
    Fetal Diagn Ther; 2010; 28(1):47. PubMed ID: 20587995
    [No Abstract]   [Full Text] [Related]  

  • 34. Recent advances in maternal serum screening for Down syndrome.
    Messerlian GM; Canick JA
    Med Health R I; 2002 Dec; 85(12):362-5. PubMed ID: 12593353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prenatal diagnosis of trisomy 21 between 1991 and 1999 in the Leuven Centre for Human Genetics: effect of triple test screening.
    Witters I; Legius E; Matthijs G; Fryns JP
    Genet Couns; 2002; 13(2):199-202. PubMed ID: 12150224
    [No Abstract]   [Full Text] [Related]  

  • 36. [Non-invasive prenatal testing is a breakthrough in prenatal screening].
    Hornstrup LS; Ambye L; Sørensen S; Jørgensen FS
    Ugeskr Laeger; 2015 Jul; 177(28):. PubMed ID: 26239855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intermediate interstitial deletion of chromosome 7q detected by first-trimester Down's syndrome screening.
    Cheong ML; Tsai MS; Cortes RA; Harrison MR
    Fetal Diagn Ther; 2008; 24(4):340-4. PubMed ID: 18841024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complete trisomy 21 vs translocation Down syndrome: a comparison of modes of ascertainment.
    Bornstein E; Lenchner E; Donnenfeld A; Jodicke C; Keeler SM; Kapp S; Divon MY
    Am J Obstet Gynecol; 2010 Oct; 203(4):391.e1-5. PubMed ID: 20691415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current controversies in prenatal diagnosis 1: should noninvasive DNA testing be the standard screening test for Down syndrome in all pregnant women?
    Bianchi DW; Oepkes D; Ghidini A
    Prenat Diagn; 2014 Jan; 34(1):6-11. PubMed ID: 24002925
    [No Abstract]   [Full Text] [Related]  

  • 40. Prenatal reflex DNA screening for trisomy 21, 18 and 13.
    Wald NJ
    Expert Rev Mol Diagn; 2018 May; 18(5):399-401. PubMed ID: 29633889
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.